| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERN.09.139 |
| P698 | PubMed publication ID | 20021317 |
| P50 | author | Marco Mula | Q28559537 |
| P2093 | author name string | Francesco Monaco | |
| Antonella Ester Marotta | |||
| P2860 | cites work | Rapid cycling bipolar disorder - diagnostic concepts | Q22242605 |
| The postictal state: a neglected entity in the management of epilepsy | Q28212574 | ||
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study | Q29616193 | ||
| The evolving bipolar spectrum. Prototypes I, II, III, and IV. | Q33768203 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders | Q33925909 | ||
| The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 | ||
| Validity of the mood disorder questionnaire: a general population study | Q34167575 | ||
| A permanent change in brain function resulting from daily electrical stimulation | Q34225550 | ||
| The natural history of epilepsy: an epidemiological view. | Q34349568 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment | Q34550618 | ||
| Antidepressant drugs: indications and guidelines for use in epilepsy | Q34570588 | ||
| Antipsychotic drugs and epilepsy: indications and treatment guidelines | Q34570593 | ||
| Negative effects of antiepileptic drugs on mood in patients with epilepsy | Q34580773 | ||
| Psychotropic effects of antiepileptic drugs | Q34589572 | ||
| Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports | Q34601847 | ||
| The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence | Q34628339 | ||
| Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials | Q34893595 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression | Q35024109 | ||
| Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment | Q35074484 | ||
| Peri-Ictal Behavioral and Cognitive Changes. | Q35074501 | ||
| Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 | ||
| Neurobiology of seizures and behavioral abnormalities | Q35798223 | ||
| The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. | Q35975365 | ||
| The effects of lamotrigine on the pharmacokinetics of lithium | Q36055287 | ||
| The structure of lifetime manic-hypomanic spectrum | Q36070621 | ||
| The bipolar spectrum: diagnostic and pharmacologic considerations | Q36310055 | ||
| Antiepileptic drug-induced mania in patients with epilepsy: what do we know? | Q36556140 | ||
| Is there a continuity between bipolar and depressive disorders? | Q36710703 | ||
| Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions | Q36888606 | ||
| Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review | Q37111491 | ||
| Psychopharmacology of topiramate: from epilepsy to bipolar disorder | Q37166152 | ||
| Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders | Q37172696 | ||
| Neurochemical underpinnings in bipolar disorder and epilepsy | Q40416216 | ||
| Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism | Q40776483 | ||
| A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures | Q41189037 | ||
| Antidepressants and seizures: clinical anecdotes overshadow neuroscience | Q41234975 | ||
| Mania precipitated by carbamazepine withdrawal | Q42557492 | ||
| Topiramate induced manic episode | Q42563500 | ||
| Relevance of new psychotropic drugs for the neurologist | Q43070261 | ||
| First break of mania associated with topiramate treatment | Q43689762 | ||
| Extending indications for long-term pharmacotherapy: opportunities and challenges | Q43843034 | ||
| On the prevalence of bipolar disorder in epilepsy | Q44703851 | ||
| Zonisamide-induced depression and mania in patients with epilepsy | Q44717938 | ||
| Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors | Q44893909 | ||
| Topiramate can cause lithium toxicity | Q45045075 | ||
| The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant | Q46708775 | ||
| Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period | Q48320278 | ||
| Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy | Q48473722 | ||
| Oxcarbazepine improves mood in patients with epilepsy. | Q50909818 | ||
| Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. | Q51032804 | ||
| Prodromal symptoms in epileptic patients: clinical characterization of the pre-ictal phase. | Q51875058 | ||
| Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. | Q51895857 | ||
| Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. | Q52004793 | ||
| Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. | Q53615836 | ||
| A review of valproate in psychiatric practice | Q56093713 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 13-23 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Epilepsy and bipolar disorders | |
| P478 | volume | 10 |
| Q36917377 | A review of potassium channels in bipolar disorder |
| Q48445326 | Differences in vulnerability to nicotine-induced kindling between female and male periadolescent rats. |
| Q38575703 | Epilepsy and bipolar disorder |
| Q38721462 | Epilepsy and stigmatization in Turkey |
| Q26744625 | Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models |
| Q35518878 | Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump |
| Q92897635 | Mood Disorders in Epilepsy |
| Q36244774 | Parental and comorbid epilepsy in persons with bipolar disorder |
| Q37880900 | Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications |
| Q40067214 | Systematic Review of Cognitive Function in Euthymic Bipolar Disorder and Pre-Surgical Temporal Lobe Epilepsy. |
Search more.